Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
13 Mai 2024 - 2:30PM
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision
medicine company transforming the drug discovery process by
combining leading-edge computational and experimental technologies,
today announced that the company will host a New Program and
Platform event on Thursday, June 6, 2024 from 8:00 to 10:00 a.m.
ET. During the event, the company will disclose new programs from
its existing pre-clinical pipeline and review how the Dynamo™
platform led to these novel discoveries.
The event will be a hybrid format, with limited in-person
attendance available to members of the investment community, and a
simultaneous webcast will be available for all interested parties
who wish to join virtually.
The live presentation can be accessed through Relay
Therapeutics’ website under “Events” in the News & Events
section through the following link:
https://ir.relaytx.com/news-events/events-presentations. An
archived replay of the webcast will be available for up to 30 days
following the event. To participate in the live webcast, please
register for the event here. It is recommended that participants
register at least 15 minutes in advance of the event.
About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine
company transforming the drug discovery process by combining
leading-edge computational and experimental technologies with the
goal of bringing life-changing therapies to patients. As the first
of a new breed of biotech created at the intersection of
complementary techniques and technologies, Relay Therapeutics aims
to push the boundaries of what’s possible in drug discovery. Its
Dynamo™ platform integrates an array of leading-edge computational
and experimental approaches designed to drug protein targets that
have previously been intractable or inadequately addressed. Relay
Therapeutics’ initial focus is on enhancing small molecule
therapeutic discovery in targeted oncology and genetic disease
indications. For more information, please visit www.relaytx.com or
follow us on Twitter.
Contact:Megan Goulart617-545-5526
mgoulart@relaytx.com
Media:Dan
Budwick1AB973-271-6085dan@1abmedia.com
Relay Therapeutics (NASDAQ:RLAY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Relay Therapeutics (NASDAQ:RLAY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024